Key Bridge Compliance’s Novo Nordisk NVO Stock Holding History

Key Bridge Compliance’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$4.03M	Buy	+44,290	New	+$3.9M	1.26%	21

Other funds holding NVO

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Key Bridge Compliance's NVO Position: Q3 2023 in Review

Key Bridge Compliance opened a new position in Novo Nordisk (NVO) in Q3 2023: 44,290 shares worth $4.03M. The stake represents 1.26% of the portfolio and ranks #21 among its holdings.

1,306 funds tracked by Wall St. Rank hold NVO as of Q3 2023.

Key Bridge Compliance held 44,290 shares of Novo Nordisk worth $4.03M as of Q3 2023.
Novo Nordisk was a new Key Bridge Compliance position in Q3 2023.
Novo Nordisk made up 1.26% of Key Bridge Compliance's portfolio in Q3 2023, its #21 holding.
1,306 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2023.

Based on Key Bridge Compliance's 13F filing for Q3 2023, filed 13 Oct 2023.